Publication | Open Access

Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial

Cationic Liposomal PaclitaxelPhase Ii TrialPancreatic CancerGastrointestinal OncologyMedicinePharmacologyAdvanced Pancreatic CancerCancer TreatmentOncologyRadiation Oncology